Suppr超能文献

产前饮食教育与补充,以增加能量和蛋白质摄入量。

Antenatal dietary education and supplementation to increase energy and protein intake.

作者信息

Ota Erika, Hori Hiroyuki, Mori Rintaro, Tobe-Gai Ruoyan, Farrar Diane

机构信息

Department of Health Policy, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan, 157-8535.

出版信息

Cochrane Database Syst Rev. 2015 Jun 2(6):CD000032. doi: 10.1002/14651858.CD000032.pub3.

Abstract

BACKGROUND

Gestational weight gain is positively associated with fetal growth, and observational studies of food supplementation in pregnancy have reported increases in gestational weight gain and fetal growth.

OBJECTIVES

To assess the effects of education during pregnancy to increase energy and protein intake, or of actual energy and protein supplementation, on energy and protein intake, and the effect on maternal and infant health outcomes.

SEARCH METHODS

We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2015), reference lists of retrieved studies and contacted researchers in the field.

SELECTION CRITERIA

Randomised controlled trials of dietary education to increase energy and protein intake, or of actual energy and protein supplementation, during pregnancy.

DATA COLLECTION AND ANALYSIS

Two review authors independently assessed trials for inclusion and assessed risk of bias. Two review authors independently extracted data and checked for accuracy. Extracted data were supplemented by additional information from the trialists we contacted.

MAIN RESULTS

We examined 149 reports corresponding to 65 trials. Of these trials, 17 were included, 46 were excluded, and two are ongoing. Overall, 17 trials involving 9030 women were included. For this update, we assessed methodological quality of the included trials using the standard Cochrane criteria (risk of bias) and the GRADE approach. The overall risk of bias was unclear. Nutritional education (five trials, 1090 women) Women given nutritional education had a lower relative risk of having a preterm birth (two trials, 449 women) (risk ratio (RR) 0.46, 95% CI 0.21 to 0.98, low-quality evidence), and low birthweight (one trial, 300 women) (RR 0.04, 95% CI 0.01 to 0.14). Head circumference at birth was increased in one trial (389 women) (mean difference (MD) 0.99 cm, 95% CI 0.43 to 1.55), while birthweight was significantly increased among undernourished women in two trials (320 women) (MD 489.76 g, 95% CI 427.93 to 551.59, low-quality evidence), but did not significantly increase for adequately nourished women (MD 15.00, 95% CI -76.30 to 106.30, one trial, 406 women). Protein intake increased significantly (three trials, 632 women) (protein intake: MD +6.99 g/day, 95% CI 3.02 to 10.97). No significant differences were observed on any other outcomes such as neonatal death (RR 1.28, 95% CI 0.35 to 4.72, one trial, 448 women, low-quality evidence), stillbirth (RR 0.37, 95% CI 0.07 to 1.90, one trial, 431 women, low-quality evidence), small-for-gestational age (RR 0.97, 95% CI 0.45 to 2.11, one trial, 404 women, low-quality evidence) and total gestational weight gain (MD -0.41, 95% CI -4.41 to 3.59, two trials, 233 women). There were no data on perinatal death. Balanced energy and protein supplementation (12 trials, 6705 women)Risk of stillbirth was significantly reduced for women given balanced energy and protein supplementation (RR 0.60, 95% CI 0.39 to 0.94, five trials, 3408 women, moderate-quality evidence), and the mean birthweight was significantly increased (random-effects MD +40.96 g, 95% CI 4.66 to 77.26, Tau² = 1744, I² = 44%, 11 trials, 5385 women, moderate-quality evidence). There was also a significant reduction in the risk of small-for-gestational age (RR 0.79, 95% CI 0.69 to 0.90, I² = 16%, seven trials, 4408 women, moderate-quality evidence). No significant effect was detected for preterm birth (RR 0.96, 95% CI 0.80 to 1.16, five trials, 3384 women, moderate-quality evidence) or neonatal death (RR 0.68, 95% CI 0.43 to 1.07, five trials, 3381 women, low-quality evidence). Weekly gestational weight gain was not significantly increased (MD 18.63, 95% CI -1.81 to 39.07, nine trials, 2391 women, very low quality evidence). There were no data reported on perinatal death and low birthweight. High-protein supplementation (one trial, 1051 women)High-protein supplementation (one trial, 505 women), was associated with a significantly increased risk of small-for-gestational age babies (RR 1.58, 95% CI 1.03 to 2.41, moderate-quality evidence). There was no significant effect for stillbirth (RR 0.81, 95% CI 0.31 to 2.15, one trial, 529 women), neonatal death (RR 2.78, 95% CI 0.75 to 10.36, one trial, 529 women), preterm birth (RR 1.14, 95% CI 0.83 to 1.56, one trial, 505 women), birthweight (MD -73.00, 95% CI -171.26 to 25.26, one trial, 504 women) and weekly gestational weight gain (MD 4.50, 95% CI -33.55 to 42.55, one trial, 486 women, low-quality evidence). No data were reported on perinatal death. Isocaloric protein supplementation (two trials, 184 women)Isocaloric protein supplementation (two trials, 184 women) had no significant effect on birthweight (MD 108.25, 95% CI -220.89 to 437.40) and weekly gestational weight gain (MD 110.45, 95% CI -82.87 to 303.76, very low-quality evidence). No data reported on perinatal mortality, stillbirth, neonatal death, small-for-gestational age, and preterm birth.

AUTHORS' CONCLUSIONS: This review provides encouraging evidence that antenatal nutritional education with the aim of increasing energy and protein intake in the general obstetric population appears to be effective in reducing the risk of preterm birth, low birthweight, increasing head circumference at birth, increasing birthweight among undernourished women, and increasing protein intake. There was no evidence of benefit or adverse effect for any other outcome reported.Balanced energy and protein supplementation seems to improve fetal growth, and may reduce the risk of stillbirth and infants born small-for-gestational age. High-protein supplementation does not seem to be beneficial and may be harmful to the fetus. Balanced-protein supplementation alone had no significant effects on perinatal outcomes.The results of this review should be interpreted with caution. The risk of bias was either unclear or high for at least one category examined in several of the included trials, and the quality of the evidence was low for several important outcomes. Also, as the anthropometric characteristics of the general obstetric population is changing, those developing interventions aimed at altering energy and protein intake should ensure that only those women likely to benefit are included. Large, well-designed randomised trials are needed to assess the effects of increasing energy and protein intake during pregnancy in women whose intake is below recommended levels.

摘要

背景

孕期体重增加与胎儿生长呈正相关,孕期食物补充的观察性研究报告了孕期体重增加和胎儿生长的增加。

目的

评估孕期教育以增加能量和蛋白质摄入量,或实际能量和蛋白质补充对能量和蛋白质摄入量的影响,以及对母婴健康结局的影响。

检索方法

我们检索了Cochrane妊娠与分娩组试验注册库(2015年1月31日)、检索到的研究的参考文献列表,并联系了该领域的研究人员。

选择标准

孕期饮食教育以增加能量和蛋白质摄入量,或实际能量和蛋白质补充的随机对照试验。

数据收集与分析

两位综述作者独立评估试验是否纳入并评估偏倚风险。两位综述作者独立提取数据并检查准确性。提取的数据由我们联系的试验人员提供的额外信息补充。

主要结果

我们审查了与65项试验对应的149份报告。其中,17项试验被纳入,46项试验被排除,2项试验正在进行。总体而言,纳入了涉及9030名女性的17项试验。对于本次更新,我们使用Cochrane标准(偏倚风险)和GRADE方法评估了纳入试验的方法学质量。总体偏倚风险尚不清楚。营养教育(5项试验,1090名女性)接受营养教育的女性早产风险较低(2项试验,449名女性)(风险比(RR)0.46,95%CI 0.21至0.98,低质量证据),低出生体重风险较低(1项试验,300名女性)(RR=0.04,95%CI 0.01至0.14)。一项试验(389名女性)中出生时头围增加(平均差(MD)0.99cm,95%CI 0.43至1.55),而两项试验(320名女性)中营养不良女性的出生体重显著增加(MD 489.76g,95%CI 427.93至551.59,低质量证据),但营养充足女性的出生体重未显著增加(MD 15.00,95%CI -76.30至106.30,1项试验,406名女性)。蛋白质摄入量显著增加(3项试验,632名女性)(蛋白质摄入量:MD+6.99g/天,95%CI 3.02至10.97)。在任何其他结局上未观察到显著差异,如新生儿死亡(RR 1.28,95%CI 0.35至4.72,1项试验,448名女性,低质量证据)、死产(RR 0.37,95%CI 0.07至1.90,1项试验,431名女性,低质量证据)、小于胎龄儿(RR 0.97,95%CI 0.45至2.11,1项试验,404名女性,低质量证据)和孕期总增重(MD -0.41,95%CI -4.41至3.59,2项试验,233名女性)。没有围产期死亡的数据。能量和蛋白质平衡补充(12项试验,6705名女性)接受能量和蛋白质平衡补充的女性死产风险显著降低(RR 0.60,95%CI 0.39至0.94,五5项试验),3408名女性,中等质量证据),平均出生体重显著增加(随机效应MD+40.96g,95%CI 4.66至77.26,Tau²=1744,I²=44%,11项试验,5385名女性,中等质量证据)。小于胎龄儿的风险也显著降低(RR 0.79,95%CI 0.69至0.90,I²=16%,7项试验,4408名女性,中等质量证据)。未检测到早产(RR 0.96,95%CI 0.80至1.16,5项试验,3384名女性,中等质量证据)或新生儿死亡(RR 0.68,95%CI 0.43至1.07,5项试验,3381名女性,低质量证据)的显著影响。每周孕期体重增加未显著增加(MD 18.63,95%CI -1.81至39.07,9项试验,2391名女性,极低质量证据)。没有围产期死亡和低出生体重的报告数据。高蛋白补充(1项试验,1051名女性)高蛋白补充(一项试验,505名女性)与小于胎龄儿风险显著增加相关(RR 1.58,95%CI 1.03至2.41,中等质量证据)。死产(RR 0.81,95%CI 0.31至2.15,一项试验,529名女性)、新生儿死亡(RR 2.78,95%CI 0.75至10.36,一项试验,529名女性)、早产(RR 1.14,95%CI 0.83至1.56,一项试验,505名女性)、出生体重(MD -73.00,95%CI -171.26至25.26,一项试验,504名女性)和每周孕期体重增加(MD 4.50,95%CI -33.55至42.55,一项试验,486名女性,低质量证据)均无显著影响。没有围产期死亡的报告数据。等热量蛋白质补充(2项试验,184名女性)等热量蛋白质补充(2项试验,184名女性)对出生体重(MD 108.25,95%CI -220.89至437.40)和每周孕期体重增加(MD 110.45,95%CI -82.87至303.76,极低质量证据)无显著影响。没有围产期死亡率、死产、新生儿死亡、小于胎龄儿和早产的报告数据。

作者结论

本综述提供了令人鼓舞的证据,即旨在增加一般产科人群能量和蛋白质摄入量的产前营养教育似乎可有效降低早产、低出生体重的风险,增加出生时头围,增加营养不良女性的出生体重,并增加蛋白质摄入量。对于报告的任何其他结局,均未发现有益或有害影响。能量和蛋白质平衡补充似乎可改善胎儿生长,并可能降低死产和小于胎龄儿出生的风险。高蛋白补充似乎并无益处,可能对胎儿有害。单纯等热量蛋白质补充对围产期结局无显著影响。本综述的结果应谨慎解释。在一些纳入试验中,至少有一个审查类别中的偏倚风险尚不清楚或很高,并且几个重要结局的证据质量较低。此外,由于一般产科人群的人体测量特征正在发生变化,那些开发旨在改变能量和蛋白质摄入量的干预措施的人员应确保仅纳入可能受益的女性。需要进行大型、设计良好的随机试验,以评估孕期能量和蛋白质摄入量低于推荐水平的女性增加能量和蛋白质摄入量的效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验